CTEP (also called RO4956371; RO 4956371; RO-4956371) is a long-acting and orally bioavailable allosteric antagonist of metabotropic glutamate receptor 5 (mGlu5) receptor with important biological activity.

Pomaglumetad (LY404039; LY-404039; LY-404,039; LY404,039) is a novel and potent agonist of recombinant human mGlu2/mGlu3 receptors with the potential for the treatment of Schizophrenia.

Ro 25-6981 is a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit.

Ifenprodill Tartrate (RC61-91; RC6191; RC6191; RC-6191), the tartrate salt of Ifenprodill, is a potent and atypical noncompetitive antagonist at the NMDA/N-methyl-D-aspartate receptor with a wide variety of activities such as central nervous system (CNS) stimulating, anti-inflammatory, neuroprotective, and anti-fibrotic effects.

(-)-Dizocilpine Maleate [also known as (-)-MK-801; MK801; MK 801], the maleate salt of dizocilpine, is a novel, potent, selective and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist with potential to treat a wide range of neurodegenerative conditions or disorders in which NMDA receptors play an important role.

ADX47273 (ADX-47273; BA-94673139; BA94673139) is a potent, selective and specific mGlu5 positive allosteric modulator(PAM) with important biological activity.

VU 0364439 (VU0364439; VU-0364439) is a mGlu4 (metabotropic glutamate receptor 4) positive allosteric modulator (PAM) with important biological activity.

CNQX (FG9065; FG-9065; 6-cyano-7-nitroquinoxaline-2,3-dione) is an AMPA/kainate antagonist that inhibits AMPA and kainate receptors with IC50 values of 0.3 μM, 1.5 μM, respectively.

Dizocilpine Maleate [formerly (+)-MK-801)], the maleate salt of (+)dizocilpine, is a non-competitive antagonist of NMDA (N-Methyl-D-aspartate) receptors with a Kd of 37.2 nM in rat brain membranes.

Evans Blue (Direct Blue 53) is a potent inhibitor of the uptake of L-glutamate into synaptic vesicles, it is also an AMPA/kainate receptor antagonist.